ADAMTS 13 AUTOANTIBODY / CITRATED PLASMA

image not found

NABL Cap Accredited 

ADAMTS 13 Autoantibody / Citrated Plasma test detects autoantibodies against the ADAMTS13 enzyme, which is crucial in the regulation of blood clotting. It is primarily used to diagnose or monitor acquired thrombotic thrombocytopenic purpura (TTP). Metropolis Healthcare provides precise testing using advanced immunoassay techniques for reliable results. This test helps clinicians confirm autoimmune involvement and guide treatment decisions for clotting disorders. Results from Metropolis Healthcare are accurate, clinically actionable, and easy to interpret.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 8,400.00

Sample Type: CITRATED PLASMA

Fasting Not Required


Notes: A0662

Frequently Asked Questions (FAQ's):

What does the ADAMTS 13 Autoantibody / Citrated Plasma test include at Metropolis Healthcare?
The test detects autoantibodies against ADAMTS13 in citrated plasma using Metropolis Healthcare’s advanced immunoassay methods.

How does Metropolis Healthcare perform the ADAMTS 13 Autoantibody test?
Metropolis Healthcare uses standardized immunoassay techniques with strict quality control to ensure precise and reliable results.

Who should take the ADAMTS 13 Autoantibody / Citrated Plasma test at Metropolis Healthcare?
Individuals suspected of acquired TTP, unexplained thrombocytopenia, or clotting abnormalities may be advised to take this test at Metropolis Healthcare.

What sample is required for the ADAMTS 13 Autoantibody / Citrated Plasma test at Metropolis Healthcare?
A citrated plasma sample collected by trained professionals at Metropolis Healthcare is required for testing.

How should I prepare for the ADAMTS 13 Autoantibody / Citrated Plasma test at Metropolis Healthcare?
No special preparation is usually required, but Metropolis Healthcare may provide instructions depending on clinical context.

How long does it take to receive ADAMTS 13 Autoantibody results from Metropolis Healthcare?
Results are typically available within the standard laboratory timeframe, with Metropolis Healthcare ensuring timely reporting.

What do abnormal ADAMTS 13 Autoantibody results indicate at Metropolis Healthcare?
Presence of autoantibodies suggests acquired TTP, and Metropolis Healthcare’s report helps guide diagnosis and treatment planning.

Can I consult a doctor about my ADAMTS 13 Autoantibody / Citrated Plasma results at Metropolis Healthcare?
Yes, Metropolis Healthcare supports consultations to interpret results and plan appropriate management for clotting disorders.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab